newlighttherapyinaction

MHL

M E D I L U X H E A L T H C A R E L I M I T E D
HEALTHCARE CHOICES FOR THE INTERNET AGE

L i g h t T h e r a p y i n A c t i o n

10.04.2006 New medical research, 40% increased microcirculation when using Q.Light
The goal of the present scientific research was to study possibilities of improvement of systemic and regional microcirculation after their local irradiation with polychromatic visible + IR light and with visible light only at therapeutic dose ranges.
The result shows an up to 40% increased microcirculation locally.

Q Light Phototherapy Increases Microcirculation by more than 40% - Implications for wound healing Read More . . .

Please note: some of the pictures and/or videos are of a clinical nature and show graphic wounds and other conditions which may be upsetting to some people. If you are of a sensitive nature then please do not explore this section of the site.

University Hospital Ghent, Belgium. The application of Q light Therapy in combination with pressure bandage's for the treatment of severe second degree burns. This is an excerpt from a recent television programme about the burn centre and its work with Q Light You will require Windows Media Player to be installed on your computer to view this video.

Q Light® in action

The University Hospital of Gent in Belgium (Department of Plastic and Reconstructive Surgery) has many years experience in the application of phototherapy in areas such as second degree burns, pressure sores, diabetic and venous leg ulcers and both accidental and surgical wounds. Successful results have been achieved using a range of phototherapy devices including low power laser and the Bioptron proprietary system.

The Hospital was therefore asked to try Q.Light® PRO for a year in a variety of applications in its Outpatient Clinic and its Burns Centre. In June 2007 they reported on their experience and the advantages of Q.Light® PRO over other devices. Their findings confirmed the advantages of Q.Light® PRO in three main areas:

1) Larger treatment areas, which allowed for a reduction in treatment time.

2) Ability to exclude infra-red light (felt as heat) making therapy less painful for burn patients.

3) Adjustable spectrum, allowing patient-specific therapy.

Conditions for which Q.Light® PRO were used included chemical burns, abdominal wounds, post-surgical recovery, pressure sores, diabetic 'scald', flame wounds, oil scalds, skin tears and venous ulcers. They therefore covered a range of acute and chronic wounds encountered during in the hospital over the twelve month period.

Medilux Healthcare Limited is a specialised marketing company. We promote devices on the basis of the Manufacturers' representations as to quality and efficacy and where possible we provide additional information as to the conditions which may benefit from their use but we do not guarantee that they will be suitable or effective for all purchasers. We do not examine or diagnose patients or recommend treatments and where we promote medical services this is on an information-only basis. Patients contract directly with these providers and all clinical decisions are made by them alone.